MOLECULAR CHARACTERIZATION OF PATIENTS WITH APL ENTERED INTO THE UK MRC ATRA TRIAL - RELATIONSHIP OF PML BREAKPOINT WITH ADDITIONAL CYTOGENETIC ABNORMALITIES AND OUTCOME
D. Grimwade et al., MOLECULAR CHARACTERIZATION OF PATIENTS WITH APL ENTERED INTO THE UK MRC ATRA TRIAL - RELATIONSHIP OF PML BREAKPOINT WITH ADDITIONAL CYTOGENETIC ABNORMALITIES AND OUTCOME, Blood, 90(10), 1997, pp. 271-271